de Haan L - Search Results

1

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group. Di Forti M, et al. Among authors: de haan l. Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19. Lancet Psychiatry. 2019. PMID: 30902669 Free PMC article.

2

Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH. Velthorst E, et al. Among authors: de haan l. Schizophr Res. 2009 Apr;109(1-3):60-5. doi: 10.1016/j.schres.2009.02.002. Epub 2009 Mar 9. Schizophr Res. 2009. PMID: 19272756

3

Subjective effects of cannabis before the first psychotic episode.

Peters BD, de Koning P, Dingemans P, Becker H, Linszen DH, de Haan L. Peters BD, et al. Among authors: de haan l, de koning p. Aust N Z J Psychiatry. 2009 Dec;43(12):1155-62. doi: 10.3109/00048670903179095. Aust N Z J Psychiatry. 2009. PMID: 20001415

4

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.

Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Korver N, et al. Among authors: de haan l. Aust N Z J Psychiatry. 2010 Mar;44(3):230-6. doi: 10.3109/00048670903487118. Aust N Z J Psychiatry. 2010. PMID: 20180725

5

Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis.

Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH. Dragt S, et al. Among authors: de haan l. Can J Psychiatry. 2010 Mar;55(3):165-71. doi: 10.1177/070674371005500308. Can J Psychiatry. 2010. PMID: 20370967

6

Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.

Machielsen M, van der Sluis S, de Haan L. Machielsen M, et al. Among authors: de haan l. Aust N Z J Psychiatry. 2010 Aug;44(8):721-8. doi: 10.3109/00048671003689710. Aust N Z J Psychiatry. 2010. PMID: 20636193

7

Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms.

Boyette L, Swets M, Meijer C, Wouters L; GROUP Authors. Boyette L, et al. Psychiatry Res. 2011 Apr 30;186(2-3):409-13. doi: 10.1016/j.psychres.2010.07.048. Epub 2010 Aug 30. Psychiatry Res. 2011. PMID: 20800902 Free article.

8

Disability in people clinically at high risk of psychosis.

Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, Schultze-Lutter F, Klosterkötter J, Ruhrmann S. Velthorst E, et al. Among authors: de haan l. Br J Psychiatry. 2010 Oct;197(4):278-84. doi: 10.1192/bjp.bp.109.075036. Br J Psychiatry. 2010. PMID: 20884950

9

Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study.

Lataster J, van Os J, de Haan L, Thewissen V, Bak M, Lataster T, Lardinois M, Delespaul PA, Myin-Germeys I. Lataster J, et al. Among authors: de haan l. J Clin Psychiatry. 2011 Oct;72(10):1397-404. doi: 10.4088/JCP.09m05466yel. J Clin Psychiatry. 2011. PMID: 21208588

10

Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients.

Buizer-Voskamp JE, Muntjewerff JW; Genetic Risk and Outcome in Psychosis (GROUP) Consortium Members; Strengman E, Sabatti C, Stefansson H, Vorstman JA, Ophoff RA. Buizer-Voskamp JE, et al. Biol Psychiatry. 2011 Oct 1;70(7):655-62. doi: 10.1016/j.biopsych.2011.02.015. Epub 2011 Apr 13. Biol Psychiatry. 2011. PMID: 21489405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

930 results

Search Page

Filters